Physician profile
Christopher R Tomaras
NPI 1881780633
$1,543,139.00
in general payments reported to CMS, 2019-2025
18 companies · $459K in 2025
The $459K reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,651 · 2020: $78K · 2021: $171K · 2022: $248K · 2023: $306K · 2024: $275K · 2025: $459K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.0M · Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,038,927.54 |
| Food and Beverage | $734.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $1,540,282.66 | 2019-2025 | Sable, Affirm, Corridor |
| Mirus, LLC | $1,250.00 | 2019 | |
| Medtronic, INC. | $329.17 | 2021-2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $273.28 | 2020-2025 | Intracept Rf Probe, Intracept |
| Relievant Medsystems, INC. | $198.71 | 2022-2023 | Intracept |
| Baxter Healthcare | $134.96 | 2022-2024 | Floseal |
| Renovis Surgical Technologies, INC. | $131.42 | 2019 | |
| Cerapedics INC. | $119.00 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Spineart USA INC | $81.18 | 2022 | |
| Nevro Corp. | $71.27 | 2019 | |
| Medtronic USA, INC. | $71.14 | 2020 | |
| Arteriocyte Medical Systems, INC. | $55.76 | 2023-2024 | Magellan |
| Electronic Waveform Lab, INC. | $40.33 | 2019 | |
| Curonix LLC | $28.30 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stryker Corporation | $23.81 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $21.12 | 2024 | Proclaim |
| Spineology INC. | $14.64 | 2023 | Optimesh Expandable Interbody Fusion System |
| Spr Therapeutics, INC | $12.25 | 2023 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Tomaras listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.